Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study.Published in:Health Technology Assessment, 2021, v. 25, n. 17, p. vii, doi. 10.3310/hta25170By:Robinson, Danielle E.;Ali, M. Sanni;Strauss, Victoria Y.;Elhussein, Leena;Abrahamsen, Bo;Arden, Nigel K.;Ben-Shlomo, Yoav;Caskey, Fergus;Cooper, Cyrus;Dedman, Daniel;Delmestri, Antonella;Judge, Andrew;Javaid, Muhammad Kassim;Prieto-Alhambra, DanielPublication type:Article